Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

James Brown

Obstetrics & Gynecology North Syracuse, NY Medical Doctor

NPI 1538159447 CMS profile 24604

729 1/2 N Main St, North Syracuse, NY 13212

Open in the dashboard

General payments

$5,645

41 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, James Brown of North Syracuse, NY is reported in the CMS Open Payments database as having received $5,645 across 41 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $65 2
2023 General $62 3
2022 General $58 2
2021 General $109 9
2020 General $3,241 7
2019 General $2,110 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Brown
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to James Brown were reported at $0. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year James Brown Obstetrics & Gynecology median Middle half National median
2019 $2,110 $172 $62–$391 $163
2020 $3,241 $94 $36–$222 $114
2021 $109 $136 $42–$369 $132
2022 $58 $160 $50–$433 $149
2023 $62 $169 $56–$423 $160
2024 $65 $152 $50–$371 $164
2025 $0 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Minerva Surgical, Inc $5,197 15 payments
  2. AbbVie, Inc. $182 13 payments
  3. Bayer HealthCare Pharmaceuticals Inc. $65 2 payments
  4. Boston Scientific Corporation $48 1 payment
  5. Allergan Inc. $35 2 payments
  6. Mayne Pharma Inc. $27 1 payment
  7. Pfizer Inc. $16 1 payment
  8. Agile Therapeutics, Inc. $14 1 payment
  9. Sumitomo Pharma America, Inc. $14 1 payment
  10. Mission Pharmacal Company $12 1 payment
  11. Other $35 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,000 2 payments
  2. Consulting Fee $1,500 1 payment
  3. Food and Beverage $644 35 payments
  4. Travel and Lodging $501 3 payments
Products named General payments · program years 2019–2024
  1. Minerva ES $3,193 4 payments
  2. Genesys HTA $3,193 4 payments
  3. Symphion $3,193 4 payments
  4. Resectr $3,193 4 payments
  5. Endometrial Ablation System (Device) $2,003 11 payments
  6. LO LOESTRIN FE $170 12 payments
  7. Mirena $65 2 payments
  8. Orilissa Endocrinology $47 3 payments
  9. ORILISSA Womens Health $38 2 payments
  10. ORIAHNN $38 2 payments
  11. Other $92 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

41 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record